Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
1,669,703
-
Shares change
-
+544,145
-
Total reported value, excl. options
-
$18,785,205
-
Value change
-
+$5,932,208
-
Number of buys
-
3
-
Number of sells
-
-2
-
Price
-
$11.23
Significant Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q4 2023
7 filings reported holding ROIV - Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share as of Q4 2023.
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,669,703 shares
of 695,088,397 outstanding shares and own 0.24% of the company stock.
Largest 10 shareholders include QVT Financial LP (112,541,536 shares), SB INVESTMENT ADVISERS (UK) LTD (73,031,667 shares), VIKING GLOBAL INVESTORS LP (69,368,961 shares), FMR LLC (36,976,248 shares), MORGAN STANLEY (21,927,044 shares), BlackRock Inc. (20,805,601 shares), Rubric Capital Management LP (19,000,000 shares), STATE STREET CORP (13,727,418 shares), WELLINGTON MANAGEMENT GROUP LLP (13,640,416 shares), and Patient Square Capital LP (12,639,920 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.